Login / Signup

Immune checkpoint inhibitors in cancer: the increased risk of atherosclerotic cardiovascular disease events and progression of coronary artery calcium.

Bingxin GongYusheng GuoYi LiJing WangGuofeng ZhouYong-Hao ChenTong NieMing YangKun LuoChuansheng ZhengFeng PanBo LiangLian Yang
Published in: BMC medicine (2024)
Treatment with ICIs was associated with a higher rate of ASCVD events and a noticeable increase in CAC progression.
Keyphrases
  • coronary artery
  • cardiovascular disease
  • papillary thyroid
  • pulmonary artery
  • type diabetes
  • squamous cell carcinoma
  • combination therapy
  • pulmonary arterial hypertension
  • pulmonary hypertension
  • smoking cessation